Alvotech declined 2.34% in premarket trading, despite reporting strong financial results for the first six months of 2025, including over 200% growth in product revenues year-on-year and a best quarter in terms of operating cash flows. The company also announced continued expansion of commercial partnerships for pipeline assets and its listing on the Nasdaq Stockholm Market.
Comments
No comments yet